This review focuses on the published data regarding the molecular determinants (enzymes, transporters, orphan nuclear receptors) of Catharanthus (vinca) alkaloids pharmacokinetics in humans. The clinical impact of these determinants (drug disposition, drug-drug interactions) is also discussed.
No takes yet. Share an insight, caveat, or question.
Levêque et al. (2007) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: